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Ante-mortem detection of chronic wasting disease in
recto-anal mucosa-associated lymphoid tissues from elk
(Cervus elaphus nelsoni) using real-time quaking-induced
conversion (RT-QuIC) assay: A blinded collaborative study
Sireesha Mannea, Naveen Kondrua, Tracy Nicholsb,#, Aaron Lehmkuhlc,
Bruce Thomsenc,y, Rodger Maind, Patrick Halburd, Somak Duttae,
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bUnited States Department of Agriculture (USDA), National Wildlife Research Center,
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ABSTRACT. Prion diseases are transmissible spongiform encephalopathies (TSEs) characterized by
fatal, progressive neurologic diseases with prolonged incubation periods and an accumulation of
infectious misfolded prion proteins. Antemortem diagnosis is often difficult due to a long
asymptomatic incubation period, differences in the pathogenesis of different prions, and the presence
of very low levels of infectious prion in easily accessible samples. Chronic wasting disease (CWD) is a
TSE affecting both wild and captive populations of cervids, including mule deer, white-tailed deer, elk,
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moose, muntjac, and most recently, wild reindeer. This study represents a well-controlled evaluation of
a newly developed real-time quaking-induced conversion (RT-QuIC) assay as a potential CWD
diagnostic screening test using rectal biopsy sections from a depopulated elk herd. We evaluated 69
blinded samples of recto-anal mucosa-associated lymphoid tissue (RAMALT) obtained from USDA
Veterinary Services. The results were later un-blinded and statistically compared to
immunohistochemical (IHC) results from the USDA National Veterinary Services Laboratories
(NVSL) for RAMALT, obex, and medial retropharyngeal lymph node (MRPLN). Comparison of
RAMALT RT-QuIC assay results with the IHC results of RAMALT revealed 92% relative sensitivity
(95% confidence limits: 61.52–99.8%) and 95% relative specificity (95% confidence limits: 85.13–
99%). Collectively, our results show a potential utility of the RT-QuIC assay to advance the
development of a rapid, sensitive, and specific prion diagnostic assay for CWD prions.
KEYWORDS. Ante-mortem test, chronic wasting disease (CWD), elk, immunohistochemistry
(IHC), medial retropharyngeal lymph node (MRPLN), obex, prion, real-time quaking-induced
conversion (RT-QuIC) assay, recto-anal mucosa-associated lymphoid tissue (RAMALT)
INTRODUCTION
Chronic wasting disease (CWD) is a type of
transmissible spongiform encephalopathy (TSE)
that affects a wide range of captive and wild cer-
vids such as elk, white-tailed deer, mule deer,
moose, muntjac, reindeer1-5 and can experimen-
tally be transmitted to swine.6 CWD was first
identified in Colorado and has since expanded to
several states and territories of North America
including Iowa, Wisconsin and Illinois.4,7 CWD
has also been reported in South Korea, Canada
and very recently in Norway.1 Conversion of
normal cellular prion protein (PrPC) into its
abnormally folded isoform, disease-associated
prion protein (PrPD), results in protease resis-
tance and the consequent accumulation of PrPD,
which serves as the diagnostic marker to identify
prion infectivity.8,9 PrPC is involved in various
biological functions such as cell signaling, metal
homeostasis, apoptosis and oxidative stress.10-13
CWD achieves efficient horizontal transmission
to neighboring animals because PrPD becomes
widely distributed among the lymph nodes, ner-
vous tissue3,14,15 and blood,16 and it is also
excreted in other body fluids where it persists in
the environment.17-19 The presence of abnormal
PrPD serves as an important marker to diagnose
CWD. In white-tailed deer, PrPD accumulation
in brain tissues is preceded by its accumulation
in several lymphoid tissues like tonsils, lymph
nodes, and gut-associated lymphoid tissue.20,21,22
Thus, given the potential for earlier detection,
this peripheral tissue distribution was exploited
in the utilization of rectal biopsies for antemor-
tem screening of scrapie, thus helping surveil-
lance programs in Canada and the US since
2006 and 2008, respectively.4,5 Due to the rapid
and widespread nature of CWD in captive and
free-ranging animals, the serious concern that
needs to be addressed is how to detect the dis-
ease early enough in live animals from both cap-
tive and wild populations for intervention
measures to halt the spread of the disease.19,23
To date, several diagnostic methods have been
approved as official regulatory test methods in
the US to detect PrPD, such as immunohis-
tochemistry (IHC), Western blot, and ELISA.
However, the utility of these assays is limited to
postmortem tissues (such as obex and medial
retropharyngeal lymph nodes) in the case of cer-
vids with CWD.
New protein-misfolding amplification plat-
forms such as real-time quaking-induced conver-
sion (RT-QuIC) and serial protein-misfolding
cyclic amplification (PMCA) assays have
recently been evaluated for their utility in detect-
ing PrPD, as well as for their sensitivity and spec-
ificity. However, the diagnostic utility of these
techniques has not been rigorously tested for cer-
vid biopsies. The RT-QuIC and PMCA assays
show great promise for developing new tests that
will enable us to detect prion disease early in
live animals.24,25 Furthermore, the RT-QuIC
assay is well documented for its flexibility and
versatility utilizing a high-throughput format. To
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detect PrPD in CWD cases, most of the current
diagnostic methods use brainstem, medial retro-
pharyngeal lymph node (MRPLN), and palatine
tonsils from postmortem animals. In white-tailed
deer and elk, utilizing recto-anal mucosa-associ-
ated lymphoid tissue (RAMALT) and other lym-
phoid tissue biopsies provides promising sample
tools for antemortem diagnosis of CWD. Also,
collecting RAMALT from live animals is a rela-
tively simple and reliable procedure that has
already been adopted for use in experimental ani-
mals and sheep populations and could be trans-
lated to field conditions for both captive and wild
cervid management.20,26-28,29,30 Despite these
advancements in diagnosing prion diseases, sev-
eral challenges still need to be addressed for sen-
sitive and specific detection of CWD in early
stages of infection.
In the present study, researchers from Iowa
State University, USDA Wildlife Services, and
USDA Veterinary Services employed a blinded
study design to evaluate the ability of the RT-
QuIC assay to detect CWD from post-mortem
RAMALT samples in an elk herd of 69 animals
depopulated due to CWD infection. The
RAMALT RT-QuIC assay results correlated
well with the IHC detection of PrPD from the
RAMALT and with the severity of prion
infection. Our study identifies RAMALT
samples as a suitable candidate for the
RT-QuIC assay and compares RT-QuIC with
currently approved testing methods. Our results
demonstrate that RAMALT could be adopted
for the antemortem diagnosis of CWD. With
the validation of RT-QuIC assay for RAMALT
samples, CWD could be diagnosed from live
elk, increasing the number of strategies
available to prevent the spread of the disease.
RESULTS
Determination of Quality of Substrate Used
for RT-QuIC Assay
The purity of substrate is a key determinant
of protein misfolding kinetics in the RT-QuIC
assay. Therefore, we first tested the purity of
our in-house generated, Syrian Hamster recom-
binant prion protein (SHrPrP) (residues
90–231). The high-purity recombinant prion
protein was generated using the bacterial
expression system and isolated by affinity chro-
matography under denaturing conditions, and
on-column refolding followed by elution of pro-
tein (as described in methods, Fig. 1A, top
panel). Biochemical characterization of the
SHrPrP using total protein stain (Ponceau)
revealed that the protein was maximally pure
(Fig. 1A, middle panel). We also performed
Western blot analysis of the purified protein
using a mouse monoclonal 6D11 antibody,
which revealed a single band specific for PrP
immunoreactivity at »16 kD molecular weight
(Fig. 1A, bottom panel). Additionally, we used
FIGURE 1. Biochemical and biophysical characterization of purified Syrian Hamster recombinant
prion protein (SHrPrP) (90–231 residues). (A) The top panel is the elution of rPrP using FPLC. The
middle panel consists of total protein stain using Ponceau S solution. The bottom panel is the West-
ern blot analysis of eluted rPrP using 6D11 antibody. The numbers 1–9 in the middle panel show
samples loaded in each well during Western blot. Lane 1 represents molecular weight standards.
Lanes 2–7 represent the protein fractions collected at different steps of protein purification. Lanes
5 & 7 (black lines) represent the early and late peak fractions, respectively, during elution of protein.
Lane 6 (red line) represents the middle of the peak fraction of the eluted protein, which is used as a
substrate in the RT-QuIC assay. Lane 8 represents the positive control, which is also an SHrPrP
(90–231), from Dr. Caughey and colleagues, used as a reference. (B) Total protein stain (Ponceau
S) and Western blot analysis of pooled SHrPrP (90–231) of purified protein and a positive control
with the 6D11 antibody. The first lane is molecular weight standards, the second lane is purified pro-
tein and the third lane is a positive control. (C & D) NMR and CD spectroscopy images of SHrPrP
(90–231). The blue line represents the SHrPrP (90–231) positive control purified at the Caughey
lab, and the red line represents SHrPrP (90–231) that we purified. (E) AFR in the RT-QuIC assay
using reference protein and purified protein as substrates. The blue bar indicates reference protein,
while the red bar indicates purified protein.
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SHrPrP (residues 90–231) received from Dr.
Caughey and colleagues from the NIH Rocky
Mountain Laboratory31 as a positive control.
This was loaded in lane 8 of the Western blot
(Fig. 1A), corresponding to the same molecular
weight as our lab-purified protein in lane 6
(center of the peak fraction during elution of
protein), which was used in the RT-QuIC assay.
Total protein stain and Western blot analysis of
SHrPrP from our lab and the positive control
from Caughey’s lab are shown in Fig. 1B. Next,
we performed biophysical characterization of
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the substrate using NMR spectroscopy. The
spectra revealed the purity and homogeneity of
the substrate and conformation of the alpha heli-
cal-rich protein (Fig. 1C). Furthermore, CD
spectroscopy of the purified protein confirmed
the high a-helical content of its secondary struc-
ture (Fig. 1D). For NMR and CD spectroscopy,
we also plotted our lab-purified protein against
positive controls from the Caughey lab. Lastly,
mass spectroscopy indicated >99% purity of
the rPrP (data not shown).
Along with other confirmatory tests, we also
compared purified protein in the RT-QuIC
assay, from which it is evident that both the
reference protein and purified protein have sim-
ilar amyloid formation rates (AFR) (Fig. 1E).
AFR was derived by taking the inverse of the
time to cross the threshold fluorescence, which
was defined as the control mean fluorescence
plus 5 standard deviations.32 Every purified
batch of the rPrP90–231 was validated using total
protein stain, Western blotting and test plates
with known standards before using in the RT-
QuIC assay.
Optimal Seed Concentration of Recto-Anal
Mucosa-Associated Lymphoid Tissue
(RAMALT) Samples for RT-QuIC Analysis
As in many assays, it is imperative to quan-
tify the amount of seed needed for the assay.
Too much or too little seed may reduce the sen-
sitivity of the RT-QuIC assay. Therefore, to
determine the optimal seed concentration of a
RAMALT sample that works best in the
RT-QuIC assay, we did a serial log dilution of
a known positive control RAMALT sample.
The sample was homogenized with phosphate-
buffered saline (PBS) to 10% and later diluted
(in 0.05% SDS/PBS) to generate concentrations
(%) of 2, 2 £ 10¡1, 2 £ 10¡2, 2 £ 10¡3, 2 £
10¡4 and so on until 2 £ 10¡7. From each seri-
ally diluted homogenate, 5 ml was added to
95 ml of the RT-QuIC reaction mixture
(described in Methods), thus further diluting
the seed in the well. Seed concentrations of 2 £
10¡2 and 2 £ 10¡3 amplified optimally com-
pared to all other dilutions, which amplified at
later time points (Fig. 2A). When different
seed concentrations from the serial dilution
were plotted against the AFR, a linear relation-
ship was observed for those seeded with a posi-
tive control. High AFR values indicate the
sample is crossing the threshold at an early
time point and has a low lag period, making it
more suitable for testing. Threshold-crossing
time for any sample depends on its seed con-
centration. No amyloid was formed when nega-
tive seeds were used (Fig. 2B). All RAMALT
samples from 69 elk were tested using 2 £
10¡2 dilution in the RT-QuIC assay (Fig. 2C &
2D). The RT-QuIC fluorescence amplification
readout showed a clear increase in fluorescence
intensity in CWD-positive samples as com-
pared to negative controls.
CWD Status of the Herd
Immunohistochemical (IHC) analysis of
obex, MRPLN, and RAMALT (Fig. 3A and
3B) were independently performed in all 69
elk samples at the National Veterinary Serv-
ices Laboratories, but the RT-QuIC analysis
was done at Iowa State University and only
for RAMALT samples. Out of 69 elk, 51 were
MM, and 17 were ML genotypes at codon 132
in the Prnp gene; genotyping data were not
available for one animal, so only 68 animals
were used for data analysis (Table 1). Among
the 51 MM animals, IHC analyses identified
14 animals that were CWD-positive in both
the obex and MRPLN, one in obex sample
only, and six in MRPLN only. For RAMALT
samples, both IHC and the RT-QuIC assay
identified 10 animals that were positive by
IHC of obex and MRPLN. Of the 17 ML
animals, IHC analyses identified 2 animals
that were CWD-positive in IHC of both the
obex and MRPLN, and two in obex only.
However, IHC and RT-QuIC analyses of
RAMALT samples only identified 2 animals
as CWD-positive (Table 1). This discrepancy
in PrPD detections when comparing RAMALT
results to those of obex and MRPLN may be
due to lack of PrPD in tested samples. Samples
positive by IHC analysis of obex were scored
as 0, 1, 2, 3 & 4 based on a previously reported
methodology33 (Table 1). Collectively, 19/68
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(28%) elk samples were CWD-positive by
IHC of obex, and 22/68 (32%) were positive
by IHC of MRPLN. Notably, out of these posi-
tive animals, IHC of RAMALT identified 12
positives, and RT-QuIC analysis of RAMALT
identified 14 positives.
RAMALT RT-QuIC and IHC Test Results
Based on genotyping and other diagnostic
test results, CWD is more prevalent in animals
homozygous for MM at the Prnp codon 132
since more positives were observed in MM
FIGURE 2. Choosing optimal working dilution and testing RAMALT samples in the RT-QuIC assay.
(A) Different dilutions of a positive control on the RT-QuIC assay. Each dilution ran in triplicate.
The 2 £ 10¡2 dilution was used for all tested samples. (B) AFR for different dilutions of a positive
control. The 2 £ 10¡2 dilution has more AFR and is significantly different. Asterisks *p  0.05 and
***p < 0.001 added to show the sample concentrations that were significantly different.
(C) Amplification kinetics of positive and negative elk RAMALT samples along with controls. Blue
trace represents the RAMALT sample that tested positive in the RT-QuIC assay. (D) AFR of
RAMALT sample along with a positive control. The blue bar indicates a representative trace of one
RAMALTsample.
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animals compared to those with the ML geno-
type (Fig. 4A). This is consistent with the pre-
vious reports.34,35 To evaluate the RAMALT
RT-QuIC results, we used the Receiver Operat-
ing Characteristics (ROC) curve, which plots
sensitivity versus 1-specificty of a diagnostic
test. The specificity of RT-QuIC versus a diag-
nostic test (e.g., IHC) is calculated as TN/
(TNCFP), where TN (true negative) is the
number of samples identified as negative (not
infected) by both tests and FP (false positive) is
the number of samples identified as positive
(infected) by RT-QuIC but negative by the
other test (e.g., IHC). The area under the curve
(AUC) represents the accuracy of the test and
offers a way to quantitatively compare two or
FIGURE 3. Isolation and immunohistochemical detection of PrPD from RAMALT sample. (A) Dis-
section of recto-anal mucosal (RA) junction to isolate mucosa-associated lymphoid tissue (MALT)
for RAMALT sample. (B) Immunohistochemistry of RAMALT from elk (Cervus elaphus nelsoni).
Note the proteinase-resistant prion staining (red chromogen) distribution within the lymphoid follicle
located in the lamina propria. Staining was done using a mouse monoclonal antibody F99/97.6.1
against epitopes at residues 220–225 of prion protein and developed with streptavidin-alkaline
phosphatase method. The slides were further counterstained with hematoxylin (blue stain).
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TABLE 1. Summary of CWD status by IHC and RT-QuIC assay results.
Animal
number Genotype
IHC of
obex
Obex
score
IHC of
MRPLN
IHC of
RAMALT
CWD
status
RT-QuIC of
RAMALT
1 MM P 4 P P P P
2 MM ND ND ND ND ND
3 MM ND ND ND ND ND
4 MM ND ND ND ND ND
5 MM ND ND ND ND ND
6 ML ND ND ND ND ND
7 MM ND ND ND ND ND
8 ML P 1 ND P P P
9 MM ND ND ND ND ND
10 MM P 3 P P P P
11 MM ND ND ND/I ND ND
12 ML P 1 P ND P ND
13 MM ND ND ND ND ND
14 ML ND ND ND ND ND
15 MM ND ND ND ND ND
16 MM ND 0 P ND P P
17 MM P 1 P P P P
18 ML ND ND ND ND ND
19 MM ND ND ND ND ND
20 ML ND ND ND ND ND
21 MM ND ND ND ND ND
22 MM ND ND ND ND ND
23 MM ND 0 P ND P ND
24 ML ND ND ND ND ND
25 MM ND ND ND ND ND
26 MM ND ND ND ND ND
27 MM ND 0 P ND P ND
28 ML ND ND ND ND ND
29 MM P 3 P P P P
30 MM P 2 P P P P
31 MM ND ND ND ND ND
32 MM P 3 P P P P
33 MM ND ND ND ND ND
34 MM ND ND ND ND ND
35 ML ND ND ND ND ND
36 MM ND ND ND ND ND
37 MM ND ND ND ND ND
38 MM ND ND ND ND ND
39 ML ND ND ND ND ND
40 MM ND ND ND ND ND
41 MM ND ND ND ND ND
42 ML ND ND ND ND ND
43 ML P 1 ND ND P ND
44 ML ND ND ND ND ND
45 MM ND ND ND ND ND
46 MM ND 0 P ND P ND
47 MM P 2 P ND P ND
48 MM P 1 ND ND P ND
49 ML ND ND ND ND ND
50 MM P 2 P P P ND
51 MM ND 0 P ND P ND
52 ML ND ND ND ND ND
53 MM P 1 P ND P ND
54 MM P 2 P ND P ND
55 ML ND ND ND ND ND
(Continued on next page)
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more diagnostic tests. Here, we compared the
RAMALT RT-QuIC results with IHCs of
RAMALT, obex, and MRPLN samples. In gen-
eral, an AUC >90% indicates high accuracy.
IHC of RAMALT and RAMALT RT-QuIC
assay (Fig. 4B) share 93.1% AUC. Thus,
RAMALT RT-QuIC assay results were closely
comparable to RAMALT IHC results. Overall,
the correlation between IHC of RAMALT and
those of RT-QuIC analyses was nearly 81%
(Table 2). By comparing RAMALT samples,
the relative sensitivity and relative specificity
of the RT-QuIC assay and IHC were 92% and
95%, respectively. The sensitivity of the RT-
QuIC assay for RAMALT samples with other
tests like IHC’s of obex and MRPLN is 50%
along with 95% specificity.
Discussion
The lack of an antemortem diagnostic test
for CWD is a concerning problem. CWD’s
widespread nature and very long incubation
TABLE 1. (Continued )
Animal
number Genotype
IHC of
obex
Obex
score
IHC of
MRPLN
IHC of
RAMALT
CWD
status
RT-QuIC of
RAMALT
56 MM P 3 P P P P
57 ML P 3 P P P P
58 MM ND ND ND ND ND
59 MM ND ND ND ND ND
60 MM ND ND ND ND ND
61 MM P 3 P P P P
62 MM ND ND ND ND ND
63 MM P 1 P P P P
64 MM ND ND ND ND P
65 MM P 1 P ND P ND
66 MM ND ND ND ND P
67 MM ND ND ND ND ND
68 MM ND 0 P ND P ND
Total MM- 51 P- 19 0- 6; P- 22 P- 12 P- 25 P- 14
ML- 17 ND- 49 1- 8; ND- 46 ND- 56 ND- 43 ND- 54
2- 4;
3- 6;
4- 1
The number of animals testing positive and negative for CWD were tabulated. Out of 69 samples, genotyping was available for only 68 ani-
mals. IHC of MRPLN detected the highest number of positives followed by IHC of obex, RT-QuIC assay of RAMALTand IHC of RAMALT. Sam-
ples that were positive in IHC of obex were scored as 0, 1, 2, 3 & 4 based on the distribution and extent of PrPD in the brain. Obex score of zero
represents elk that were MRPLN-positive but had no staining in the obex, and a score of one represents the minimal distribution of PrPD
around vagal nuclei with higher scores indicating more extensive distributions. A score of 4 represents widespread distribution in the gray and
white matter of the brainstem. P D positive; ND D not detected, ND/I D not detected, insufficient follicles.
TABLE 2. Correlation between various tests.
Variable By variable Correlation Lower 95% Upper 95%
RAMALT RT-QuIC IHC of RAMALT 0.8144 0.7156 0.8812
IHC of obex IHC of RAMALT 0.7443 0.6162 0.8341
IHC of obex RAMALT RT-QuIC 0.5764 0.3934 0.7155
IHC of MRPLN IHC of RAMALT 0.5886 0.4089 0.7244
IHC of MRPLN RAMALT RT-QuIC 0.5054 0.3053 0.6628
IHC of MRPLN IHC of obex 0.6922 0.5447 0.7981
Correlation between different diagnostic tests with upper and lower 95% confidence intervals. When comparing all detection procedures, the
outcome of the RT-QuIC analysis of RAMALT was highly correlated to those of IHC results demonstrating the efficacy of RT-QuIC assay for
CWD detection in RAMALTsamples.
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FIGURE 4. CWD status of the herd. (A) Stacked bar graph showing infectivity of different tissues
from MM and ML genotypes at PrP codon 132. Red bars indicate the number of animals that are
negative for CWD, while the blue bars indicate CWD-positive animals. (B) ROC curves of RAMALT
RT-QuIC assay compared against other IHC tests. An AUC >90% indicates high accuracy. Among
different IHC’s, IHC of RAMALT has highest AUC which is 93.1%, indicating RAMALT RT-QuIC
assay results were comparable to RAMALT IHC results.
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period warrants the pressing need for a robust
antemortem test for early diagnosis, which
would reduce much of the uncertainty plaguing
modern herd management. Recently, the RT-
QuIC assay has been experimentally used for
diagnosing Creutzfeldt–Jakob disease (CJD),36
scrapie,37 and CWD.38 Very recently, we have
reported that the RT-QuIC assay can be readily
adopted for a rapid detection of prion infection
using an ex vivo brain culture model.39 Though
the RT-QuIC assay was developed to rapidly
diagnose misfolded prions from human sam-
ples, the seed used has been mostly limited to
post-mortem samples like brain tissue.
Although attempts were made to detect PrPD
in noninvasive samples from biofluids like
blood or saliva, the presence of inhibitors that
interfere with aggregation limits their utility
as diagnostic samples in RT-QuIC assays.40-42
More recently, nasal brushings from human
patients with CJD showed the promising diag-
nostic application in the antemortem diagnosis
of prion disease using RT-QuIC43 and
PMCA.44 However, elk nasal brushings did
not form a good seed in the RT-QuIC assay
for early cases since cervid olfactory sensory
neurons are not infected until later stages of
CWD.34 In elk, abnormal prions accumulate
in the brain, lymph nodes in the head, and
spread to peripheral lymphoid tissues like
RAMALT.45 In the current study, we have
evaluated a highly sensitive RT-QuIC assay to
detect CWD using RAMALT samples in a
blinded fashion. IHC of RAMALT, obex, and
MRPLN were also performed. We noticed a
slight increase in the number of positives
found in animals with MM polymorphism at
codon 132 when compared to the ML geno-
type. This is consistent with previous reports
showing higher CWD prevalence rate within
this genotype.34,35 Based on the RT-QuIC
analysis of RAMALT samples, we observed a
strong correlation between the RT-QuIC assay
and IHC of RAMALT sample results, which
agree with earlier reports.33 Therefore, the
RT-QuIC assay has the potential to be a useful
and complementary diagnostic tool, especially
given the accessibility of RAMALT samples
for CWD diagnosis. Advantages of the assay,
including the need for only a minor amount of
tissue, and simplified sample preparation and
reading of results, are making it a widely used
and versatile technique. The low tissue
requirements for the RT-QuIC assay also
minimize the amount of trauma experienced
by the animal during sample collection.46
However, unlike the comparison with
RAMALT IHC, we observed a relatively
low (»50%) sensitivity for RAMALT RT-
QuIC assay results when compared with IHC
testing of obex and MRPLN samples. The
low sensitivity is likely due to the variability
of PrPD tissue distribution in elk (compared
to other animals) together with the fact that
we only used a small quantity of RAMALT
tissues in the RT-QuIC assay. Therefore, if a
selected sample of RAMALT tissue did not
contain any PrPD, the RT-QuIC test would
be falsely negative for that animal. This
could potentially be avoided by making
homogenate from all the available RAMALT
tissue and further preparing the seed from
this homogenate. Nonetheless, the higher
sensitivity of RAMALT RT-QuIC assay
when compared with IHC of RAMALT
results demonstrated that the RT-QuIC assay
is useful for detecting CWD from RAMALT
samples. The comparison of RAMALT RT-
QuIC assay results with the obex grades
demonstrates that animals with higher obex
grades (3 and above) are more likely to be
positive in the RT-QuIC assay than those
with lower obex grades, indicating that
disease state is highly variable between
animals.
In summary, we evaluated the diagnostic
performance of the RT-QuIC assay for RAM-
ALT samples from captive elk in a blinded
manner. Comparing standard IHC and RT-
QuIC assays of RAMALT samples revealed
that these two are well correlated.
Further improvements in the RT-QuIC
seeding assays for cervids could enhance
optimal screening to achieve greater sensitiv-
ity and specificity. This could be achieved
using other species of rPrP, by optimizing
assay conditions, using mouse bioassays and
other diagnostic tests like PMCA as well.
For example, transgenic mice expressing
bank vole PrP are highly susceptible to a
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wide variety of prion diseases and rPrP-
expressing bank vole PrP (BVrPrP) was able
to detect many prion diseases including
human prions in the RT-QuIC assay.47 Simi-
larly, BVrPrP and cervid rPrP could be
important alternate substrates for diagnosing
CWD, but this still remains to be tested. We
are progressing towards developing an effi-
cient and sensitive RT-QuIC assay for ante-
mortem samples to screen herds for CWD
status, which will assist in deploying rapid
control and/or preventive measures to better
manage CWD.
MATERIALS AND METHODS
Purification of Syrian Hamster
Recombinant Prion Protein (SHrPrP)
SHrPrP encoding a 90–231 amino acid
sequence was transformed, expressed in E. coli
Rosetta cells (EMD Millipore) and purified
using previously published methods.39,48,49 In
brief, the SHr PrP-expressing Rosetta strain
DE2 of E. coli was inoculated into lysogeny
broth (LB) along with auto-induction system1
(EMD Millipore) and selection antibiotics.
After the cultures were induced overnight, the
bacteria were harvested after reaching optical
density 3 at 600 nm. Inclusion bodies were iso-
lated from these cell pellets by treating with 1X
Bug Buster (EMD Millipore) followed by 0.1X
Bug Buster and centrifugation at 13000 £ g for
15 minutes. Then the inclusion bodies were
denatured in 8 M guanidine hydrochloride
(GuHCl) in 100 mM Na Phosphate at pH 8
using OMNI International Tissue Homogenizer
and rotated for 50 min at RT. Next, the solution
with denatured protein was centrifuged at 8000
£ g for 5 min and the supernatants were added
to Ni-NTA superflow resin (Qiagen) that had
been equilibrated in denaturing buffer [100 mM
sodium phosphate (pH 8.0), 10 mM Tris, 6 M
GuHCl]. To allow rPrP to bind to beads, Ni-
NTA superflow resin along with denatured rPrP
was incubated on a rotator for 40 min at RT.
Later, the beads were packed in an Akta XK26
column at RT. Subsequent steps were carried
out under refrigerated conditions for fast protein
liquid chromatography using Bio-Rad Duoflow.
Refolding of rPrP was attained on the column
by using a gradient from denaturing buffer to
refolding buffer (100 mM NaPO4, 10 mM Tris
[pH 8.0]). After refolding, rPrP was eluted from
the column using a gradient from refolding
buffer to elution buffer (100 mM NaPO4,
10 mM Tris [pH 8.0], 500 mM imidazole [pH
5.5]) (Fig. 1A, Top panel). Fractions from the
middle of the peak were collected and mixed
with pre-chilled dialysis buffer (10 mM NaPO4
[pH 5.5]) and dialyzed with three sets of 3.6 L
of dialysis buffer.
Tissue Processing and RT-QuIC Method
After collection, samples were stored in a
¡80C freezer until being tested. RAMALT
samples measuring 0.3–0.5 cm were dis-
sected from larger rectal biopsies collected
1 cm anterior to the mucocutaneous junction
(Fig. 3A). This tissue was first homogenized
to 10% (w/v) in PBS with the help of a Bul-
let Blender (Next Advance) using 0.5-mm
Zirconium oxide beads in 1.5-mL screw cap
tubes. Conditions for homogenization are
three 5-min cycles at a speed setting of 10.
Next, the homogenates were diluted to 2%
(w/v) in PBS. The samples were then diluted
in RT-QuIC dilution buffer (0.05% SDS in
PBS).32 Next, 5 ml of 0.02% rectal biopsy
homogenate was added as a seed to 95 ml of
RT-QuIC reaction buffer (1X PBS supple-
mented with 220 mM NaCl, 10 mM EDTA,
10 mM Thioflavin T (ThT), and 0.1 mg/ml
rPrP), in each well of a 96-well plate. We
evaluated each rectal biopsy sample (3 repli-
cates per sample) against a blank, as well as
positive and negative controls in a 96-well
flat-bottomed (Nunc) plates. Later, the sealed
plates were analyzed using a Cytation 3
multi-mode plate reader (BioTek) at 42C
with shaking (807 rpm, double orbital) and
rest cycles that alternated every minute for
24 h. Fluorescence readings of ThT were
bottom-read at 450-nm excitation and
480-nm emission every 15 min using a gain
setting of 1200. A sample was judged to be
positive based on the previously reported
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criterion32 of when the mean of replicate
fluorescence readings crossed the predeter-
mined threshold (mean fluorescence plus
10 times the standard deviation of known
negative controls). Each sample ran in quad-
druplicate with known positive and negative
controls. After completing data analysis and
reporting results, the samples were unblinded
to reveal the true diagnostic status. Then we
calculated the AFR, which is the inverse of
the threshold-crossing time for each dilution.
We used the dilution with the highest AFR
to seed all samples.40
Biophysical and Biochemical Analyses
of rPrP Substrate
To confirm the structure of expressed trun-
cated rPrP, we performed Nuclear Magnetic Res-
onance (NMR) spectroscopy and Circular
Dichroism (CD) according to published meth-
ods.50,51 In brief, the CD spectra of the purified
protein were recorded on a Jasco J-710 Spectro-
polarimeter using a thermostatted cuvette
(Helma) with 1-mm path length. Measurements
were carried out using a protein diluted in sodium
phosphate buffer at 14C, pH 7, yielding a final
protein concentration of 8 mM. NMR spectra
were recorded using a Bruker Avance 800 spec-
trometer. The concentration of protein was
1 mM in sodium phosphate buffer along with 5%
D2O. Samples were prepared in special NMR
tubes (Catalog# 897240–0000, Kimble Chase).
In addition to the biophysical characteriza-
tion, we tested the purity of rPrP substrate
using SDS-polyacrylamide gel electrophore-
sis using previously published methods.39 To
visualize total proteins, Coomassie staining
of the gels and Ponceau S staining of mem-
branes were used. Western blotting against
prion protein used monoclonal antibody
6D11 (Catalog# SIG-399810, Covance). In
brief, proteins were loaded from different
fractions and separated on 15% SDS-PAGE
gels. After transferring the proteins onto
nitrocellulose membranes, blots were first
evaluated with Ponceau S stain (Catalog#
P7170, Sigma-Aldrich) to locate the protein
since Ponceau S does not interfere with
polypeptides. The stain was removed by
washing membranes in distilled water until
the background was clean. To block nonspe-
cific binding sites, nitrocellulose membranes
were blocked with blocking buffer (Li-Cor)
for 1 h. Later, the membranes were probed
with the primary antibody 6D11 for 20 min
at RT and washed 5 times with PBS contain-
ing 0.05% Tween 20. Then, secondary goat
anti-mouse (1:20000, Alexa flour) was used
to detect PrPC with the Odyssey IR imaging
system.
IHC on the Brainstem, RLN,
and RAMALT
The brainstem at the level of the obex, the
MRPLN and RAMALT were fixed in 10%
buffered formalin, processed, sectioned and
stained for IHC using the mouse monoclonal
primary anti-prion antibody F99/97.6.1
(Anti-Prion 99, Ventana Medical Systems)
on an automated staining system (Ventana
Medical Systems). Positive and negative
scrapie ovine control tissues were included
in each staining run and individual tissues
were diagnosed as positive or not detected
based on the presence or absence of charac-
teristic CWD chromogen deposits in the tis-
sue sections. RAMALT samples were
expected to have a minimum of six lymphoid
follicles to be a representative sample of the
rectal mucosa. A single RAMALT sample
(animal 11) had fewer than six follicles and
was scored as not detected/insufficient
follicles (Fig. 3B).33
Obex scoring was used to estimate dis-
ease progression in animals whose IHC
results for brainstem were positive follow-
ing previously published scoring crite-
ria.33,52 Briefly, an obex score of zero had
no detectable positive staining in the obex.
An obex score of one had limited staining
within the vagal nuclei and progressively
more staining in the obex equated to pro-
gressively higher scores. A maximum obex
score of four was assigned when widespread
positive staining occurred in both the gray
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and white matter throughout the entire
section of the brainstem.
Statistical Analysis
Data analysis was performed using Prism 5.0
software (GraphPad). Raw data were analyzed
using one-way ANOVA, and then Tukey’s
post-test was performed to compare different
dilutions. Differences with p  0.05 were con-
sidered significantly different, and asterisks
were assigned as follows: *p  0.05, **p <
0.01, and ***p < 0.001. ROC curves were
drawn using R statistical software.
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